CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale Chief Financial Officer sold 1,781 shares at $14.21 ($25,308)
- 4 Shares withheld for taxes President and CEO gave up 9,900 shares (to pay taxes)
- 4 Open-market sale Chief Tech. Operations Officer sold 3,500 shares at $13.51 ($47,285)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Open-market buy Director bought 2,000 shares at $19.50 ($39,000)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 140,074 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 5,850 shares at an average $23.09 ($135,089)
- 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $24.61 ($191,973)
- 4 Shares withheld for taxes Global Head of R&D gave up 4,322 shares (to pay taxes)
- 4 Open-market sale Chief Tech. Operations Officer sold 1,500 shares at $35.00 ($52,500)
- 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $33.54 ($261,582)
- 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $36.66 ($285,909)
- 4 Shares withheld for taxes Senior VP & General Counsel gave up 3,674 shares (to pay taxes)
- 4 Open-market sale Chief Tech. Operations Officer sold 1,500 shares at $39.96 ($59,940)
- 4 Open-market sale Chief Executive Officer sold 7,800 shares at an average $38.66 ($301,546)
Page 13 of 33 · 645 filings